Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Psychoneuroendocrinology

• Publication date

  2012-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.psyneuen.2011.07.020PMID 21862226PMCID PMC3353652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxytocin increases autonomic cardiac control: moderation by loneliness.

  2011cited by this paper
• Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

  2010cited by this paper
• Promoting social behavior with oxytocin in high-functioning autism spectrum disorders

  2010influential reference
• Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

  2010cited by this paper
• A pilot open label, single dose trial of fenobam in adults with fragile X syndrome

  2009cited by this paper
• Cholinergic dysfunction in fragile X syndrome and potential intervention: A preliminary 1H MRS study

  2009cited by this paper
• Treatments for fragile X syndrome: a closer look at the data.

  2009cited by this paper
• Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict.

  2009cited by this paper
• Physiological correlates of social avoidance behavior in children and adolescents with fragile x syndrome.

  2009cited by this paper
• Gene, brain, and behavior relationships in fragile X syndrome: evidence from neuroimaging studies.

  2009cited by this paper
• Using percentile schedules to increase eye contact in children with Fragile X syndrome.

  2009cited by this paper
• PRIORITY COMMUNICATION-BRIEF REPORT Oxytocin Increases Gaze to the Eye Region of Human Faces

  2008cited by this paper
• Oxytocin Attenuates Affective Evaluations of Conditioned Faces and Amygdala Activity

  2008cited by this paper
• Fragile X syndrome: assessment and treatment implications.

  2007cited by this paper
• Salivary cortisol reflects serum cortisol: analysis of circadian profiles

  2007cited by this paper
• Oxytocin increases retention of social cognition in autism.

  2007cited by this paper
• Transcription, translation and fragile X syndrome.

  2006cited by this paper
• Social Escape Behaviors in Children with Fragile X Syndrome

  2006cited by this paper
• Intranasal oxytocin administration attenuates the ACTH stress response in monkeys.

  2005cited by this paper
• Fragile X mental retardation protein levels increase following complex environment exposure in rat brain regions undergoing active synaptogenesis.

  2005cited by this paper
• Oxytocin increases trust in humans

  2005cited by this paper
• Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans

  2005cited by this paper
• Modeling cortisol rhythms in a population-based study.

  2005cited by this paper
• Anxiety and Stress Responses in Female Oxytocin Deficient Mice

  2004cited by this paper
• Oxytocin Attenuates Stress-Induced c-fos mRNA Expression in Specific Forebrain Regions Associated with Modulation of Hypothalamo–Pituitary–Adrenal Activity

  2004cited by this paper
• The neuroanatomy and neuroendocrinology of fragile X syndrome.

  2004cited by this paper
• The mGluR theory of fragile X mental retardation.

  2004cited by this paper
• Moving Molecules: mRNA Trafficking in Mammalian Oligodendrocytes and Neurons

  2004cited by this paper
• Psychopharmacology in fragile X syndrome--present and future.

  2004influential reference
• Compartmentalized Synthesis and Degradation of Proteins in Neurons

  2003cited by this paper
• Female oxytocin-deficient mice display enhanced anxiety-related behavior.

  2003cited by this paper
• Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders

  2003cited by this paper
• Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress.

  2003cited by this paper
• Compartmentalized synthesis and degradation of proteins in neurons.

  2003cited by this paper
• Sniffing neuropeptides: a transnasal approach to the human brain

  2002cited by this paper
• Cortisol and behavior in fragile X syndrome.

  2002cited by this paper
• A decade of molecular studies of fragile X syndrome.

  2002cited by this paper
• Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome.

  2001cited by this paper
• Heart rate variability in healthy children and adolescents is partially related to age and gender.

  2001cited by this paper
• Social amnesia in mice lacking the oxytocin gene

  2000cited by this paper
• Behavior and autonomic nervous system function assessed via heart period measures: The case of hyperarousal in boys with fragile X syndrome

  2000cited by this paper
• Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report.

  1999cited by this paper
• Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

  1999cited by this paper
• Neuropsychological effects of vasopressin in healthy humans.

  1998cited by this paper
• Intranasal oxytocin in obsessive-compulsive disorder.

  1996cited by this paper
• Salivary Cortisol Levels throughout Childhood and Adolescence: Relation with Age, Pubertal Stage, and Weight

  1995cited by this paper
• Transport of BC1 RNA in hypothalamo-neurohypophyseal axons

  1993cited by this paper
• Partner Preference Development in Female Prairie Voles Is Facilitated by Mating or the Central Infusion of Oxytocin a

  1992cited by this paper
• Enhanced social interactions in rats following chronic, centrally infused oxytocin.

  1992cited by this paper
• Oxytocin in obsessive compulsive disorder.

  1992cited by this paper
• Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

  1991cited by this paper
• Prevalence of fragile X syndrome.

  1991cited by this paper
• Intranasal oxytocin in obsessive-compulsive disorder.

  1987cited by this paper
• Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey

  1986cited by this paper

• Current options for the treatment of anxiety in adults with autism spectrum disorder.

  2026cites this paper
• Neurodegenerative Biomarkers in Populations with Intellectual Disabilities: Diagnostic and Therapeutic Capacities

  2025cites this paper
• Development and validation of a highly-sensitive, quantitative LC-MS/MS assay to evaluate plasma oxytocin

  2025cites this paper
• Peptide-based therapeutics targeting genetic disorders.

  2024cites this paper
• The impact of the early environment on oxytocin receptor epigenetics and potential therapeutic implications

  2024cites this paper
• Intranasal oxytocin as a treatment for anxiety and autism: from subclinical to clinical applications.

  2024cites this paper
• Differential Effects of a Behavioral Treatment Probe on Social Gaze Behavior in Fragile X Syndrome and Non-Syndromic Autism Spectrum Disorder

  2023cites this paper
• At the Head and Heart of Oxytocin’s Stress-Regulatory Neural and Cardiac Effects: A Chronic Administration RCT in Children with Autism

  2023cites this paper
• Social Anxiety in Neurodevelopmental Disorders: The Case of Fragile X Syndrome.

  2023cites this paper
• Acute intranasal oxytocin dose enhances social preference for parents over peers in male but not female peri-adolescent California mice (Peromyscus californicus).

  2023cites this paper
• Detection, processing and reinforcement of social cues: regulation by the oxytocin system

  2023cites this paper
• Sensory Symptoms and Signs of Hyperarousal in Individuals with Fragile X Syndrome: Findings from the FORWARD Registry and Database Multisite Study

  2023cites this paper
• Tales from the life and lab of a female social neuroscientist

  2023cites this paper
• Neurodevelopment and early pharmacological interventions in Fragile X Syndrome

  2023cites this paper
• Oxytocin: An expansive review of its mechanisms, functions, and therapeutic potential

  2023cites this paper
• Social communication in fragile X syndrome: pilot examination of the Brief Observation of Social Communication Change (BOSCC)

  2022cites this paper
• Neuromodulatorische Einflüsse auf das Wohlbefinden: Dopamin und Oxytocin

  2022cites this paper
• Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome.

  2022cites this paper
• Maternal Bonding in Early Infancy Predicts Childrens' Social Competences in Preschool Age

  2021cites this paper
• The Current Status of Drug Discovery for the Oxytocin Receptor.

  2021cites this paper
• Long-term exercise from adolescence to adulthood reduces anxiety- and depression-like behaviors following maternal immune activation in offspring.

  2020cites this paper
• Posterior Pituitary Hormones

  2020cites this paper
• Oxytocin as Treatment for Social Cognition, Not There Yet

  2020cites this paper
• GABA Measurement in a Neonatal Fragile X Syndrome Mouse Model Using 1H-Magnetic Resonance Spectroscopy and Mass Spectrometry

  2020cites this paper
• Oxytocin enhances the recovery of eye-contact induced autonomic arousal: A treatment mechanism study with placebo-controlled design.

  2020cites this paper
• PKC epsilon as A Neonatal Target to Correct FXS-linked AMPA Receptor Translocation in the Hippocampus, Boost PVN Oxytocin Expression, and Normalize Adult Behavior in Fmr1 Knockout Mice.

  2020cites this paper
• Parallel social information processing circuits are differentially impacted in autism

  2020cites this paper
• Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study

  2020cites this paper
• Altered steady state and activity-dependent de novo protein expression in fragile X syndrome

  2019cites this paper
• Oxytocin and Social Behaviour in Dogs and Other (Self-)Domesticated Species Methodological Caveats and Promising Perspectives

  2019cites this paper
• University of Surrey

  2019cites this paper
• Repurposing available drugs for neurodevelopmental disorders: The fragile X experience

  2019cites this paper
• Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study

  2019cites this paper
• Social Avoidance Emerges in Infancy and Persists into Adulthood in Fragile X Syndrome

  2019cites this paper
• Back-translating behavioral intervention for autism spectrum disorders to mice with blunted reward restores social abilities

  2018cites this paper
• The Oxytocin Receptor: From Intracellular Signaling to Behavior.

  2018cites this paper
• Evidence for intranasal oxytocin delivery to the brain: recent advances and future perspectives.

  2018cites this paper
• Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging

  2018cites this paper
• Neonatal Oxytocin Treatment Ameliorates Autistic-Like Behaviors and Oxytocin Deficiency in Valproic Acid-Induced Rat Model of Autism

  2018cites this paper
• Systematic review and meta‐analysis of reported adverse events of long‐term intranasal oxytocin treatment for autism spectrum disorder

  2018cites this paper
• Relationship between dietary intake and behaviors with oxytocin: a systematic review of studies in adults

  2018cites this paper
• Modelling fragile X syndrome in the laboratory setting: A behavioral perspective

  2018cites this paper
• Neonatal Stimulation of PKC Epsilon Signaling Normalizes Fragile X-Associated Deficits in PVN Oxytocin Expression and Later-Life Social and Anxiety Behavior

  2018cites this paper
• Preventing PTSD with oxytocin: effects of oxytocin administration on fear neurocircuitry and PTSD symptom development in recently trauma-exposed individuals

  2017cites this paper
• Within vs. between-subject effects of intranasal oxytocin on the neural response to cooperative and non-cooperative social interactions.

  2017cites this paper
• Increased Serum and Urinary Oxytocin Concentrations after Nasal Administration in Beagle Dogs

  2017cites this paper
• Dose-dependent social-cognitive effects of intranasal oxytocin delivered with novel Breath Powered device in adults with autism spectrum disorder: a randomized placebo-controlled double-blind crossover trial

  2017cites this paper
• Kinetics and Dose Dependency of Intranasal Oxytocin Effects on Amygdala Reactivity.

  2017cites this paper
• Oxytocin and Anxiety Disorders: Translational and Therapeutic Aspects

  2017cites this paper
• Reflections on Clinical Trials in Fragile X Syndrome

  2017cites this paper
• Oxytocin in animal models of autism spectrum disorder

  2017cites this paper
• Tracking effects of oxytocin crossing the blood brain barrier in vivo and in vitro

  2017cites this paper
• Review of Salient Investigational Drugs for the Treatment of Fragile X Syndrome

  2017cites this paper
• Emergence Of Stranger Fear In Preschoolers With Fragile X Syndrome And Idiopathic Autism Spectrum Disorder

  2017influential citation
• The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?

  2017cites this paper
• Overview of Targeted Double-Blind, Placebo-Controlled Clinical Trials in Fragile X Syndrome

  2017cites this paper
• Modelling fragile X syndrome in rats: new directions in translational research

  2017cites this paper
• Updated report on tools to measure outcomes of clinical trials in fragile X syndrome

  2017cites this paper
• The effects of intranasal oxytocin on smoothie intake, cortisol and attentional bias in anorexia nervosa.

  2017cites this paper
• The Role of the Oxytocin/Arginine Vasopressin System in Animal Models of Autism Spectrum Disorder.

  2017cites this paper
• Fragile X targeted pharmacotherapy: lessons learned and future directions

  2017cites this paper
• The effects of intranasal oxytocin on smoothie intake , cortisol and attentional bias in anorexia nervosa

  2017cites this paper
• Oxytocin and Stress-related Disorders: Neurobiological Mechanisms and Treatment Opportunities

  2017cites this paper
• Public Health Literature Review of Fragile X Syndrome

  2017cites this paper
• Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward

  2017cites this paper
• Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder

  2017cites this paper
• Characterising repetitive behaviours in young boys with fragile X syndrome.

  2016cites this paper
• Pharmacotherapy for Fragile X Syndrome: Progress to Date

  2016cites this paper
• The neurobiology of the Prader-Willi phenotype of fragile X syndrome.

  2016cites this paper
• Review of targeted treatments in fragile X syndrome.

  2016cites this paper
• Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial.

  2016cites this paper
• Pharmacotherapy for mental health problems in people with intellectual disability

  2016cites this paper
• Oxytocin in General Anxiety and Social Fear: A Translational Approach.

  2016cites this paper
• Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial

  2016cites this paper
• Conditioned social preference, but not place preference, produced by intranasal oxytocin in female mice.

  2016cites this paper
• Don't ask, don't tell: a systematic review of the extent to which participant characteristics are reported in social anxiety treatment studies

  2016cites this paper
• The impact of oxytocin administration on brain activity: a systematic review and meta-analysis protocol

  2016cites this paper
• CNTNAP2 Mutations in Autism

  2016cites this paper
• Reversal of social deficits by subchronic oxytocin in two autism mouse models.

  2016cites this paper
• Hypothalamic-pituitary-adrenal axis function in Fragile X Syndrome and its relationship to behaviour: A systematic review.

  2016cites this paper
• Genes and sex hormones interaction in neurodevelopmental disorders.

  2016cites this paper
• Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes

  2015cites this paper
• Effects of oxytocin and vasopressin on the neural response to unreciprocated cooperation within brain regions involved in stress and anxiety in men and women

  2015cites this paper
• Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment

  2015cites this paper
• Oxytocin in the socioemotional brain: implications for psychiatric disorders

  2015cites this paper
• Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism

  2015cites this paper
• New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences

  2015cites this paper
• Autism: Oxytocin, serotonin, and social reward

  2015cites this paper
• Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism

  2015cites this paper
• Developmental Perspectives on Oxytocin and Vasopressin

  2015cites this paper
• Cardiac autonomic regulation in autism and Fragile X syndrome: a review.

  2015cites this paper
• Acute and repeated intranasal oxytocin administration exerts anti-aggressive and pro-affiliative effects in male rats.

  2015cites this paper
• Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model.

  2015cites this paper
• Oxytocin: Parallel Processing in the Social Brain?

  2015cites this paper
• The Molecular Basis of Autism

  2015cites this paper
• Oxytocin and Vasopressin in Autism and Genetic Syndromes

  2015cites this paper
• Social Hormones and Human Behavior: What Do We Know and Where Do We Go from Here

  2015cites this paper
• Oxytocin mechanisms of stress response and aggression in a territorial finch.

  2015cites this paper
• Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

  2014influential citation
• The Use of Oxytocin in Personality Disorders: Rationale and Current Status

  2014cites this paper